No. 21-202
Mylan Laboratories Ltd. v. Janssen Pharmaceutica, N.V., et al.
Amici (3)Relisted (2)
Tags: 35-usc-314 35-usc-315 administrative-law appellate-jurisdiction inter-partes-review judicial-review nhk-fintiv-rule patent-trial-and-appeal-board patent-trial-and-appeals-board statutory-interpretation
Key Terms:
AdministrativeLaw Patent Trademark JusticiabilityDoctri
AdministrativeLaw Patent Trademark JusticiabilityDoctri
Latest Conference:
2022-01-14
(distributed 2 times)
Question Presented (from Petition)
1. Does 35 U.S.C. § 314(d) categorically preclude appeal of all decisions not to institute inter partes review?
2. Is the NHK-Fintiv Rule substantively and procedurally unlawful?
Question Presented (AI Summary)
Does 35 U.S.C. § 314(d) categorically preclude appeal of all decisions not to institute inter partes review?
Docket Entries
2022-01-18
Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.
2021-12-29
DISTRIBUTED for Conference of 1/14/2022.
2021-11-23
Rescheduled.
2021-11-16
DISTRIBUTED for Conference of 12/3/2021.
2021-11-16
Reply of petitioner Mylan Laboratories Ltd. filed. (Distributed)
2021-11-02
Brief of Federal Respondent in opposition filed.
2021-11-02
Brief of respondent Janssen Pharmaceutica NV in opposition filed.
2021-10-01
Motion to extend the time to file a response is granted and the time is further extended to and including November 2, 2021, for all respondents.
2021-09-30
Motion to extend the time to file a response from October 12, 2021 to November 2, 2021, submitted to The Clerk.
2021-09-13
Brief amicus curiae of Association for Accessible Medicines filed.
2021-09-13
Brief amicus curiae of Intel Corporation filed.
2021-08-25
Brief amicus curiae of Jeremy C. Doerre in support of neither party filed.
2021-08-19
Motion to extend the time to file a response is granted and the time is extended to and including October 12, 2021, for all respondents.
2021-08-18
Motion to extend the time to file a response from September 13, 2021 to October 12, 2021, submitted to The Clerk.
2021-08-09
Petition for a writ of certiorari filed. (Response due September 13, 2021)
Attorneys
Andrew Hirshfeld
Elizabeth B. Prelogar — Solicitor General, Respondent
Association for Accessible Medicines
Matthew S. Hellman — Jenner & Block LLP, Amicus
Intel Corporation
Janssen Pharmaceutica NV
Pratik Arvind Shah — Akin Gump Strauss Hauer & Feld, LLP, Respondent
Jeremy C. Doerre
Jeremy Cooper Doerre — Tillman Wright, PLLC, Amicus
Mylan Laboratories Ltd.
Robert Thomas Smith — Katten Muchin Rosenman LLP, Petitioner